Cipla

1525.10

-26.60 (-1.71%) tick

NSE

Buy Sell

NSE BSE

Last updated on 25 Apr 2025 03:33 PM

Open Demat account

Returns

0.97%

Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

125285.64

Earning Per Share

50.5

Dividend Yield

0.87%

P/E Ratio

29.60

P/B Ratio

4.30

Debt to Equity

Performance

min-value

max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value

max-value

5.34% down side

up side5.34%

About the company

Cipla Limited is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing, developing, and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs). Cipla's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. With a rich portfolio, it is deepening presence in the home markets of India, as well as South Africa, North America, and other key regulated and emerging markets. Its 47 manufacturing sites around the world produce more than 50 dosage forms and over 1,500 products across wide range of therapeutic categories.

Similar Companies

Sun Pharmaceutical

1781.8 -22.10 (-0.01%) tick

1Yr Returns

+18.66%

Mankind Pharma Limited

2557.5 -41.70 (-0.02%) tick

1Yr Returns

+8.36%

Dr. Reddys Laboratories

1174.8 -25.70 (-0.02%) tick

1Yr Returns

-3.47%

Lupin

2022 -82.10 (-0.04%) tick

1Yr Returns

+31.96%

Zydus life

859.65 -20.60 (-0.02%) tick

1Yr Returns

-7.46%